4basebio PLC (ETR:88Q)
Germany
· Delayed Price · Currency is EUR 11.50
0.00 (0.00%)
Jun 27, 2025, 5:35 PM CET
4basebio Market Cap
4basebio has a market cap or net worth of €178.94 million as of June 27, 2025. Its market cap has decreased by -32.84% in one year.
Market Cap
178.94M
Enterprise Value
155.92M
Revenue
1.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
€11.50
Market Cap Chart
Since February 17, 2021, 4basebio's market cap has increased from 47.83M to 178.94M, an increase of 274.10%. That is a compound annual growth rate of 35.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 178.94M | -4.50% |
| Dec 31, 2024 | 187.36M | 94.08% |
| Dec 29, 2023 | 96.54M | -2.09% |
| Dec 30, 2022 | 98.60M | 9.32% |
| Dec 31, 2021 | 90.19M | 88.56% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Siemens Healthineers AG | 52.36B |
| Merck KGaA | 47.98B |
| Bayer Aktiengesellschaft | 25.95B |
| Fresenius SE & Co. KGaA | 23.63B |
| Fresenius Medical Care AG | 13.93B |
| Sartorius Aktiengesellschaft | 13.35B |
| Carl Zeiss Meditec AG | 5.02B |
| Fielmann Group AG | 4.49B |